@trefoiltherapeutics.com
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
PNG
About
Description
Trefoil Therapeutics is a pioneering brand in the field of ophthalmologic drug development. They are dedicated to bringing forward innovative solutions to treat corneal diseases and prevent vision loss. At the heart of their approach is their lead candidate, TTHX1114, an engineered form of Fibroblast Growth Factor 1 (FGF1).
This compound is designed to protect corneal endothelial cells and stimulate their proliferation and migration, thereby addressing endothelial deficiencies. Trefoil's first product, currently undergoing clinical trials, is an intracameral injection of TTHX1114 for the treatment of corneal endothelial dystrophy. This injection is performed directly behind the cornea using a small needle.
Trefoil Therapeutics boasts a leadership team with over 100 years of combined experience in ophthalmology and drug development, ensuring the highest level of expertise in their field. With their cutting-edge approach and dedication to improving patient outcomes, Trefoil Therapeutics is set to revolutionize the treatment of corneal diseases
Company Type
Privately Held
Company Size
2-10
Year Founded
2013
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories